An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050753
Company: VIATRIS

Products on NDA 050753

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TOBI	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	AN	Yes	Yes

Approval Date(s) and History, Letters, Labels, Reviews for NDA 050753

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/22/1997	ORIG-1	Approval	Type 3 - New Dosage Form	PRIORITY; Orphan	Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/050753_tobi_toc.html

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/10/2023	SUPPL-28	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050753s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/050753Orig1s028ltr.pdf
12/20/2018	SUPPL-23	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050753s023lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050753Orig1s023Ltr.pdf
10/05/2018	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050753s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050753Orig1s022ltr.pdf
04/29/2016	SUPPL-19	Manufacturing (CMC)		Label is not available on this site.
10/05/2015	SUPPL-18	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050753s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/050753Orig1s018ltr.pdf
04/14/2015	SUPPL-17	Manufacturing (CMC)		Label is not available on this site.
04/25/2014	SUPPL-16	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050753s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/050753Orig1s016ltr.pdf
10/24/2013	SUPPL-15	Manufacturing (CMC)		Label is not available on this site.
09/26/2013	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050753s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/050753Orig1s011ltr.pdf
10/16/2008	SUPPL-9	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/050753s009ltr.pdf
08/05/2005	SUPPL-7	Labeling		Label is not available on this site.
09/05/2001	SUPPL-4	Manufacturing (CMC)-Packaging		Label is not available on this site.
05/18/2000	SUPPL-3	Manufacturing (CMC)		Label is not available on this site.
03/21/2002	SUPPL-2	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50753s2ltr.pdf
09/11/1998	SUPPL-1	Labeling		Label is not available on this site.

Labels for NDA 050753

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/10/2023	SUPPL-28	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/050753s028lbl.pdf
12/20/2018	SUPPL-23	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050753s023lbl.pdf
10/05/2018	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050753s022lbl.pdf
10/05/2015	SUPPL-18	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050753s018lbl.pdf
04/25/2014	SUPPL-16	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/050753s016lbl.pdf
09/26/2013	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/050753s011lbl.pdf

Therapeutic Equivalents for NDA 050753

TOBI

SOLUTION;INHALATION; 300MG/5ML
TE Code = AN

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
KITABIS PAK	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	205433	PULMOFLOW INC
TOBI	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	Yes	AN	050753	VIATRIS
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	212848	ALKEM LABS LTD
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	205501	AMNEAL PHARMS
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	207080	DR REDDYS LABS SA
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	201422	HIKMA
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	208964	LUPIN
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	214478	MANKIND PHARMA
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	217344	MICRO LABS
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	207136	SUN PHARM
TOBRAMYCIN	TOBRAMYCIN	300MG/5ML	SOLUTION;INHALATION	Prescription	No	AN	091589	TEVA PHARMS USA

Top